Real-World Data Favor Doublets in Esophageal/Gastric Cancer Real-World Data Favor Doublets in Esophageal/Gastric Cancer

Real-world data favor use of doublet chemotherapy for metastatic esophageal and gastric cancer over triplet regimens and especially over monotherapy.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news